Boxer Capital as of Sept. 30, 2024
Portfolio Holdings for Boxer Capital
Boxer Capital holds 68 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Revolution Medicines (RVMD) | 9.5 | $194M | 4.3M | 45.35 | |
| Tyra Biosciences (TYRA) | 7.4 | $152M | 6.4M | 23.51 | |
| Nuvalent Inc-a (NUVL) | 5.6 | $115M | 1.1M | 102.30 | |
| BeiGene Sponsored Adr (ONC) | 5.5 | $112M | 500k | 224.51 | |
| Cytokinetics Com New (CYTK) | 5.4 | $111M | 2.1M | 52.80 | |
| Springworks Therapeutics (SWTX) | 5.4 | $110M | 3.4M | 32.04 | |
| Merus N V (MRUS) | 4.7 | $95M | 1.9M | 49.96 | |
| Sarepta Therapeutics (SRPT) | 4.0 | $81M | 650k | 124.89 | |
| Avidity Biosciences Ord (RNA) | 3.9 | $79M | 1.7M | 45.93 | |
| Ideaya Biosciences (IDYA) | 3.4 | $70M | 2.2M | 31.68 | |
| Tango Therapeutics (TNGX) | 3.1 | $63M | 8.2M | 7.70 | |
| Argenx SE Sponsored Adr (ARGX) | 2.7 | $54M | 100k | 542.08 | |
| Apellis Pharmaceuticals (APLS) | 2.4 | $50M | 1.7M | 28.84 | |
| Akero Therapeutics (AKRO) | 2.4 | $48M | 1.7M | 28.69 | |
| Anaptysbio Inc Common (ANAB) | 2.1 | $44M | 1.3M | 33.50 | |
| Axsome Therapeutics (AXSM) | 1.8 | $36M | 400k | 89.87 | |
| Iteos Therapeutics | 1.5 | $30M | 2.9M | 10.21 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 1.4 | $29M | 600k | 48.73 | |
| Geron Corporation (GERN) | 1.3 | $27M | 6.0M | 4.54 | |
| Third Harmonic Bio (THRD) | 1.3 | $27M | 2.0M | 13.55 | |
| Rocket Pharmaceuticals (RCKT) | 1.3 | $27M | 1.5M | 18.47 | |
| Arcus Biosciences Incorporated (RCUS) | 1.2 | $25M | 1.6M | 15.29 | |
| Instil Bio Com New (TIL) | 1.2 | $24M | 356k | 67.32 | |
| Xenon Pharmaceuticals (XENE) | 1.2 | $24M | 600k | 39.37 | |
| Immunovant (IMVT) | 1.2 | $24M | 825k | 28.51 | |
| Kymera Therapeutics (KYMR) | 1.0 | $21M | 450k | 47.33 | |
| Spyre Therapeutics Com New (SYRE) | 1.0 | $21M | 697k | 29.41 | |
| Kura Oncology (KURA) | 1.0 | $20M | 1.0M | 19.54 | |
| Kalvista Pharmaceuticals (KALV) | 0.9 | $18M | 1.6M | 11.58 | |
| Nkarta (NKTX) | 0.9 | $18M | 4.0M | 4.52 | |
| Oric Pharmaceuticals (ORIC) | 0.9 | $18M | 1.7M | 10.25 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.9 | $18M | 400k | 43.89 | |
| Fate Therapeutics (FATE) | 0.9 | $17M | 5.0M | 3.50 | |
| Enliven Therapeutics (ELVN) | 0.8 | $17M | 671k | 25.54 | |
| Replimune Group (REPL) | 0.8 | $17M | 1.5M | 10.96 | |
| Day One Biopharmaceuticals I (DAWN) | 0.8 | $17M | 1.2M | 13.93 | |
| Cullinan Oncology (CGEM) | 0.7 | $15M | 908k | 16.74 | |
| Arvinas Ord (ARVN) | 0.7 | $15M | 609k | 24.63 | |
| Eliem Therapeutics (CLYM) | 0.7 | $13M | 2.6M | 5.09 | |
| Relay Therapeutics (RLAY) | 0.6 | $13M | 1.8M | 7.08 | |
| Nurix Therapeutics (NRIX) | 0.6 | $13M | 563k | 22.47 | |
| Prothena Corp SHS (PRTA) | 0.6 | $12M | 690k | 16.73 | |
| Uniqure NV SHS (QURE) | 0.5 | $11M | 2.2M | 4.93 | |
| Apogee Therapeutics (APGE) | 0.5 | $11M | 179k | 58.74 | |
| Olema Pharmaceuticals (OLMA) | 0.4 | $7.8M | 650k | 11.94 | |
| Iovance Biotherapeutics (IOVA) | 0.3 | $7.0M | 750k | 9.39 | |
| Century Therapeutics (IPSC) | 0.3 | $6.7M | 3.9M | 1.71 | |
| Jasper Therapeutics Com New (JSPR) | 0.3 | $6.6M | 350k | 18.81 | |
| Sana Biotechnology (SANA) | 0.3 | $6.4M | 1.5M | 4.16 | |
| Terns Pharmaceuticals (TERN) | 0.3 | $6.3M | 752k | 8.34 | |
| Scholar Rock Hldg Corp (SRRK) | 0.3 | $6.0M | 750k | 8.01 | |
| Poseida Therapeutics I (PSTX) | 0.3 | $5.7M | 2.0M | 2.86 | |
| Summit Therapeutics (SMMT) | 0.3 | $5.5M | 250k | 21.90 | |
| Engene Holdings (ENGN) | 0.2 | $4.8M | 728k | 6.60 | |
| Prelude Therapeutics (PRLD) | 0.2 | $3.5M | 1.7M | 2.07 | |
| Bicara Therapeutics (BCAX) | 0.2 | $3.4M | 135k | 25.47 | |
| Mersana Therapeutics | 0.2 | $3.4M | 1.8M | 1.89 | |
| Boundless Bio (BOLD) | 0.1 | $2.5M | 711k | 3.47 | |
| Black Diamond Therapeutics (BDTX) | 0.1 | $2.2M | 506k | 4.35 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.1 | $1.7M | 450k | 3.68 | |
| Protara Therapeutics Com Stk (TARA) | 0.1 | $1.5M | 812k | 1.83 | |
| Health Sciences Acq Corp 2 (OBIO) | 0.1 | $1.2M | 238k | 5.14 | |
| Zura Bio Class A Ord Shs (ZURA) | 0.1 | $1.2M | 300k | 4.06 | |
| Bioatla (BCAB) | 0.1 | $1.2M | 686k | 1.76 | |
| Milestone Pharmaceuticals (MIST) | 0.0 | $470k | 309k | 1.52 | |
| DBV Technologies S A Sponsored Adr | 0.0 | $175k | 250k | 0.70 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $26k | 267k | 0.10 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $1.3k | 67k | 0.02 |